(Q33790033)

English

Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

A Plettenberg

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

N H Brockmeyer

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

B Haastert

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

C Michalik

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S Dupke

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

K Schewe

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M Rausch

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M Hower

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A Ulmer

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

E Wolf

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

T Lorenzen

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

G Arendt

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

K Jansen

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Competence Network for HIV/AIDS

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

11 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3-12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

https://scigraph.springernature.com/pub.10.1007/s15010-010-0070-8

0 references

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

CD4+ count-guided interruption of antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Effect of early versus deferred antiretroviral therapy for HIV on survival

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

When to initiate highly active antiretroviral therapy: a cohort approach

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

The search for data on when to start treatment for HIV infection

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Initiation of antiretroviral therapy in the hospitalized patient with an acute AIDS-related opportunistic infection and other conditions: no time to lose

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

The Patient Cohort of the German Competence Network for HIV/AIDS (KompNet): a profile

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997?2003

1 reference

https://api.crossref.org/works/10.1007%2FS15010-010-0070-8

21 January 2018

Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients' preferences regarding the timing of highly active antiretroviral therapy initiation for chronic asymptomatic HIV-1 infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiological composition, clinical and treatment characteristics of the patient cohort of the German Competence Network for HIV/AIDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21221704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S15010-010-0070-8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

release_fvs7nm27zjamji3lvwkoxe7ubq

1 reference

https://api.fatcat.wiki/v0/release/fvs7nm27zjamji3lvwkoxe7ubq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33790033&oldid=1835501752"